HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

2,5-Dimethoxy-4-iodoamphetamine (DOI) inhibits Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.

Abstract
The effect of the serotonin 5-HT(2A/2C)-receptor agonist 2,5-dimethoxy-4-iodoamphetamine (DOI) on Delta(9)-tetrahydrocannabinol (THC)-induced catalepsy-like immobilization was studied in mice. DOI (0.3 and 1 mg/kg, i.p.) significantly inhibited the catalepsy-like immobilization induced by THC (10 mg/kg, i.p.). In contrast, the selective 5-HT(2C)-receptor agonist 8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one (WAY 161503) had no effect on this catalepsy-like immobilization. Moreover, the 5-HT(2A)-receptor antagonist ketanserin (0.3 mg/kg, i.p.) reversed the inhibition of THC-induced catalepsy-like immobilization caused by DOI (1 mg/kg), whereas the selective 5-HT(2C)-receptor antagonist 6-chloro-2,3-dihydro-5-methyl-N-[6-(2-methyl-3-pyridinyl)oxyl]-3-pyridinyl]-1H-indole-1-carboxyamide (SB 242084) did not affect this inhibitory effect of DOI. On the other hand, ketanserin (0.3 and 1 mg/kg, i.p.) enhanced the catalepsy-like immobilization induced by THC (6 mg/kg, i.p.). Thus, on the basis of these results, it appears that 5-HT(2A)-receptor mechanisms might be responsible for the inhibitory effect of DOI on THC-induced catalepsy-like immobilization.
AuthorsNobuaki Egashira, Emi Koushi, Kenichi Mishima, Katsunori Iwasaki, Ryozo Oishi, Michihiro Fujiwara
JournalJournal of pharmacological sciences (J Pharmacol Sci) Vol. 105 Issue 4 Pg. 361-6 (Dec 2007) ISSN: 1347-8613 [Print] Japan
PMID18057774 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 6-chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline
  • 8,9-dichloro-2,3,4,4a-tetrahydro-1H-pyrazino(1,2-a)quinoxalin-5(6H)-one
  • Aminopyridines
  • Amphetamines
  • Indoles
  • Pyrazines
  • Quinoxalines
  • Serotonin 5-HT2 Receptor Agonists
  • Serotonin Receptor Agonists
  • Dronabinol
  • Ketanserin
  • 4-iodo-2,5-dimethoxyphenylisopropylamine
Topics
  • Aminopyridines (administration & dosage, pharmacology)
  • Amphetamines (administration & dosage, pharmacology)
  • Analysis of Variance
  • Animals
  • Animals, Outbred Strains
  • Behavior, Animal (drug effects)
  • Dose-Response Relationship, Drug
  • Dronabinol (toxicity)
  • Freezing Reaction, Cataleptic (drug effects)
  • Indoles (administration & dosage, pharmacology)
  • Injections, Intraperitoneal
  • Ketanserin (administration & dosage, pharmacology)
  • Male
  • Mice
  • Pyrazines (administration & dosage, pharmacology)
  • Quinoxalines (administration & dosage, pharmacology)
  • Serotonin 5-HT2 Receptor Agonists
  • Serotonin Receptor Agonists (administration & dosage, pharmacology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: